Tedizolid (BAY119-2631)
16121
Phase 3 small_molecule completed
Quick answer
Tedizolid (BAY119-2631) for Bacterial Infections is a Phase 3 program (small_molecule) at Bayer HealthCare AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bayer HealthCare AG
- Indication
- Bacterial Infections
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed